Statistics for Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation

Total visits

views
Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation 15

Total visits per month

views
January 2024 0
February 2024 2
March 2024 3
April 2024 2
May 2024 1
June 2024 0
July 2024 0

File Visits

views
Shueb_umn_0130E_23594.pdf(legacy) 18
Shueb_umn_0130E_23594.pdf 12

Top country views

views
United States 6
United Kingdom 4
Taiwan 2
Switzerland 1
China 1
Germany 1
Hong Kong SAR China 1
Indonesia 1
Ireland 1
India 1
Russia 1
Turkey 1
Ukraine 1

Top city views

views
Chicago 2
Ankara 1
Ashburn 1
Camberley 1
Central 1
Daettlikon 1
Dublin 1
Ipswich 1
Jakarta 1
London 1
Ludhiana 1
Minneapolis 1
Rothenbach an der Pegnitz 1
Taichung 1
Valley Stream 1
Vladivostok 1